Bartus, Marilou

Bartus, Marilou was paid $149K by Medicaid between Nov 2018 and Feb 2021, across 5 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 37% of everything it billed.

33Billing provider infoBARTUS, MARILOU
BIDDEFORD, ME 04005

33aNPI1386080984assigned 05/22/2013

33bProvider typeFamily Nurse Practitioner

28Total paid$149K

24GClaims2,611

24DCodes billed5

24AFirst – last monthNov 2018 – Feb 2021

Compared with peers

Next to other Family Nurse Practitioner providers in Maine

Rank by total paid#3 of 14

Median peer was paid$12K

This provider vs. median13×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	135	$8K
2019	623	$31K
2020	1,587	$92K
2021	266	$17K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	37%	1,242	639	$55K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	35%	648	355	$51K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	22%	557	363	$32K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	6.2%	147	118	$9K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	17	15	$671.50

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.